Kremezin Side Effects

Common Kremezin Side Effects

The most commonly reported Kremezin side effects (click to view or check a box to report):

Thrombocytopenia (3)
Blood Urea Increased (2)
Alanine Aminotransferase Increased (2)
Face Oedema (2)
Aspartate Aminotransferase Increased (2)
Malaise (2)
Oedema Peripheral (2)
Palmar-plantar Erythrodysaesthesia Syndrome (2)
Diabetic Neuropathy (1)
Thirst (1)
Diabetic Ketoacidosis (1)
Anaemia (1)
Renal Failure Chronic (1)
Angioedema (1)
Interstitial Lung Disease (1)
Hypothyroidism (1)
Nephrogenic Anaemia (1)
Peritonitis (1)
Rectal Perforation (1)
Renal Failure (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Kremezin Side Effects Reported to FDA

The following Kremezin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Kremezin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Bleeding Time Prolonged, Thrombocytopenia
This is a report of a male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: renal failure chronic,hyperuricaemia,hypertension, who was treated with Kremezin (dosage: NA, start time: May 02, 2012), combined with:
  • Allopurinol
  • Lasix (40-80mg)
  • Uralyt
  • Mircera
  • Famotidine
and developed a serious reaction and side effect(s). The consumer presented with:
  • Bleeding Time Prolonged
  • Thrombocytopenia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Kremezin treatment in male patients, resulting in bleeding time prolonged side effect. The patient was hospitalized.

This report suggests a potential Kremezin (charcoal, Activated) Thirst side effect(s) that can have serious consequences. A 87-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Kremezin (charcoal, Activated) (dosage: NA) starting Feb 10, 2012. Soon after starting Kremezin (charcoal, Activated) the patient began experiencing various side effects, including:
  • Thirst
Drugs used concurrently:
  • Lansoprazole
  • Samsca (15 Mg Milligram(s), Qam, Oral)
  • Diart (azosemide) Tablet (60 Mg Milligram(s), Daily Dose, Oral)
  • Coughnol (ambroxol Hydrochloride)
  • Warfarin Sodium
  • Glucose (ascorbic Acid, Glucose)
  • Lasix (40 Mg Milligram(s), Daily Dose, Oral)
  • Calblock (azelnidipine)
Although Kremezin (charcoal, Activated) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as thirst, may still occur.

Interstitial Lung Disease
This Interstitial Lung Disease problem was reported by a physician from JAPAN. A 79-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Aug 20, 2008 this consumer started treatment with Kremezin (charcoal, Activated) (dosage: NA). The following drugs were being taken at the same time:
  • Famotidine
  • Warfarin Sodium
  • Lanirapid (metildigoxin)
  • Pletal (100 Mg Milligram(s), Bid, Oral)
  • Amoban (zopiclone)
  • Ferromia (sodium Ferrous Citrate)
  • Furosemide
When commencing Kremezin (charcoal, Activated), the patient experienced the following unwanted symptoms/side effects:
  • Interstitial Lung Disease
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as interstitial lung disease, may become evident only after a product is in use by the general population.

Angioedema, Renal Failure, Blood Pressure Increased, Nephrogenic Anaemia
This is a report of a female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Kremezin (dosage: 6 G) starting Aug 26, 2005. Concurrently used drugs:
  • Irbesartan (300 Mg)
  • Kayexalate (15 G)
  • Acetaminophen (600 Mg)
  • Aliskiren (150 Mg, Daily)
  • Amlodipine (10 Mg,)
  • Irbesartan (200 Mg)
  • Aliskiren (300 Mg, Daily)
  • Depas (1.5 Mg)
Soon after that, the consumer experienced the following side effects:
  • Angioedema
  • Renal Failure
  • Blood Pressure Increased
  • Nephrogenic Anaemia
This opens a possibility that Kremezin treatment could cause the above reactions, including angioedema, and some female subjects may be more susceptible.

Face Oedema, Thrombocytopenia, Alanine Aminotransferase Increased, Blood Urea Increased, Oedema Peripheral, Hypothyroidism, Aspartate Aminotransferase Increased, Malaise, Palmar-plantar Erythrodysaesthesia Syndrome
A 70-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Kremezin treatment (dosage: Unk) on Jan 01, 2010. Soon after starting Kremezin treatment, the subject experienced various side effects, including:
  • Face Oedema
  • Thrombocytopenia
  • Alanine Aminotransferase Increased
  • Blood Urea Increased
  • Oedema Peripheral
  • Hypothyroidism
  • Aspartate Aminotransferase Increased
  • Malaise
  • Palmar-plantar Erythrodysaesthesia Syndrome
Concurrently used drugs:
  • Magnesium Oxide (Unk)
  • Losartan Potassium (Unk)
  • Rabeprazole Sodium (Unk)
  • Persantin (Unk)
  • Amlodipine (Unk)
  • Sunitinib Malate (50 Mg, 1x/day, 28-day Administration And 14-day Cessation)
  • Sunitinib Malate (37.5 Mg/day)
  • Gaslon (Unk)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Kremezin.

Malaise, Face Oedema, Aspartate Aminotransferase Increased, Blood Urea Increased, Thrombocytopenia, Palmar-plantar Erythrodysaesthesia Syndrome, Alanine Aminotransferase Increased, Oedema Peripheral, Blood Creatinine Increased
A 70-year-old male patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Kremezin(dosage: Unk). The treatment was initiated on Jan 01, 2010. After that a consumer reported the following side effect(s):
  • Malaise
  • Face Oedema
  • Aspartate Aminotransferase Increased
  • Blood Urea Increased
  • Thrombocytopenia
  • Palmar-plantar Erythrodysaesthesia Syndrome
  • Alanine Aminotransferase Increased
  • Oedema Peripheral
  • Blood Creatinine Increased
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Kremezin efficacy:
  • Amaryl (Unk)
  • Amlodipine (Unk)
  • Rabeprazole Sodium (Unk)
  • Gaslon (Unk)
  • Sunitinib Malate (50 Mg, 1x/day, 28-day Administration And 14-day Cessation)
  • Sunitinib Malate (37.5 Mg/day)
  • Magnesium Oxide (Unk)
  • Persantin (Unk)
The patient was hospitalized.

Renal Failure Chronic
In this report, Kremezin was administered for the following condition: NA.A male consumer from SWITZERLAND (weight: NA) started Kremezin treatment (dosage: NA) on Jul 21, 2010.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Renal Failure Chronic
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Kremezin treatment could be related to the listed above side effect(s).

Diabetic Ketoacidosis, Cerebral Infarction, Cerebral Haemorrhage, Diabetic Neuropathy, Cardiac Failure, Vomiting
This is a report of the following Kremezin side effect(s):
  • Diabetic Ketoacidosis
  • Cerebral Infarction
  • Cerebral Haemorrhage
  • Diabetic Neuropathy
  • Cardiac Failure
  • Vomiting
A 63-year-old female patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Kremezin (dosage: NA) starting: Jul 21, 2010.The following concurrently used drugs could have generated interactions:
  • Apidra (Continuous Subcutaneous Insulin Infusion (csii))
  • Apidra (Continuous Subcutaneous Insulin Infusion (csii))
  • Apidra (Continuous Subcutaneous Insulin Infusion (csii))
The patient was hospitalized.This report suggests that a Kremezin treatment could be associated with the listed above side effect(s).

Peritonitis, Rectal Perforation
This Kremezin report was submitted by a 57-year-old female consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Kremezin was administered (dosage: NA) starting: Mar 01, 2011. The consumer developed a set of symptoms:
  • Peritonitis
  • Rectal Perforation
Other drugs used simultaneously:
  • Diovan
  • Calblock
  • Loxonin
  • Alfarol
  • Cytotec
  • Fosrenol (750 Mg, Unk)
  • Zyloric
  • Thyradin
Those unexpected symptoms could be linked to a Kremezin treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Kremezin Side Effects

    Did You Have a Kremezin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Kremezin for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Kremezin Safety Alerts, Active Ingredients, Usage Information

    More About Kremezin

    Side Effects reported to FDA: 9

    Kremezin safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 5

    Latest Kremezin clinical trials

    Kremezin Reviews

    No reviews, be a first to report a side effect via side effect reporting form